Jenavalve Technology

JenaValve Technology, Inc. is a medical device company specializing in the development and commercialization of transcatheter aortic valve replacement (TAVR) systems. The company focuses on providing innovative solutions for the treatment of aortic valve diseases, particularly for patients with aortic stenosis and aortic regurgitation. JenaValve generates revenue through the sale of its proprietary TAVR systems, which are designed to be minimally invasive and improve patient outcomes. Founded in 2006, the company has made significant advancements in the field of heart valve therapy, including obtaining CE Mark approval for its products, which allows them to be marketed in Europe. JenaValve continues to expand its global presence and is actively involved in clinical trials to further validate the safety and efficacy of its technologies.

Recent Posts by Jenavalve Technology

1-14 of 14